Back to Search Start Over

Advance care planning – a multi-centre cluster randomised clinical trial: the research protocol of the ACTION study

Authors :
Lesley Dunleavy
Kristian Pollock
Agnes van der Heide
Francesca Ingravallo
Jane Seymour
Johannes J.M. van Delden
Mariëtte N. Verkissen
Glenys Caswell
Luc Deliens
Anja Simonič
Esther de Vries
Caroline Arnfeldt Christensen
Ida J. Korfage
Eugenio Paci
Mogens Groenvold
Marijke C. Kars
Nancy Preston
Lea J. Jabbarian
Urska Lunder
Giuseppe Gorini
Marieke Zwakman
Judith A.C. Rietjens
Dirk Houttekier
Guido Miccinesi
Maja de Brito
Andrew Wilcock
Alenka Mimić
Sheila Payne
Francesco Bulli
Suzanne Polinder
Branka Červ
Anna Thit Johnsen
Rietjens, Judith A.C
Korfage, Ida J.
Dunleavy, Lesley
Preston, Nancy J.
Jabbarian, Lea J.
Christensen, Caroline Arnfeldt
de Brito, Maja
Bulli, Francesco
Caswell, Gleny
Červ, Branka
van Delden, Johanne
Deliens, Luc
Gorini, Giuseppe
Groenvold, Mogen
Houttekier, Dirk
Ingravallo, Francesca
Kars, Marijke C.
Lunder, Urška
Miccinesi, Guido
Mimić, Alenka
Paci, Eugenio
Payne, Sheila
Polinder, Suzanne
Pollock, Kristian
Seymour, Jane
Simonič, Anja
Johnsen, Anna Thit
Verkissen, Mariëtte N.
de Vries, Esther
Wilcock, Andrew
Zwakman, Marieke
van der Heide, Agnes
Family Medicine and Chronic Care
End-of-life Care Research Group
Faculty of Medicine and Pharmacy
Public Health
Source :
Rietjens, J A C, Korfage, I J, Dunleavy, L, Preston, N J, Jabbarian, L J, Christensen, C A, de Brito, M, Bulli, F, Caswell, G, Červ, B, van Delden, J, Deliens, L, Gorini, G, Groenvold, M, Houttekier, D, Ingravallo, F, Kars, M C, Lunder, U, Miccinesi, G, Mimić, A, Paci, E, Payne, S, Polinder, S, Pollock, K, Seymour, J, Simonič, A, Johnsen, A T, Verkissen, M N, de Vries, E, Wilcock, A, Zwakman, M & van der Heide Pl, A 2016, ' Advance care planning-a multi-centre cluster randomised clinical trial : the research protocol of the ACTION study ', BMC Cancer, vol. 16, no. 1, 264 . https://doi.org/10.1186/s12885-016-2298-x, Rietjens, J A C, Korfage, I J, Dunleavy, L, Preston, N J, Jabbarian, L J, Christensen, C A, de Brito, M, Bulli, F, Caswell, G, Červ, B, van Delden, J, Deliens, L, Gorini, G, Groenvold, M, Houttekier, D, Ingravallo, F, Kars, M C, Lunder, U, Miccinesi, G, Mimić, A, Paci, E, Payne, S, Polinder, S, Pollock, K, Seymour, J, Simonič, A, Johnsen, A T, Verkissen, M N, de Vries, E, Wilcock, A, Zwakman, M & van der Heide Pl, A 2016, ' Advance care planning-a multi-centre cluster randomised clinical trial : the research protocol of the ACTION study ', B M C Cancer, vol. 16, 264 . https://doi.org/10.1186/s12885-016-2298-x, BMC CANCER, BMC Cancer, BMC Cancer, 16. BioMed Central Ltd., BMC Cancer, 16(1). BioMed Central
Publication Year :
2016
Publisher :
Springer Science and Business Media LLC, 2016.

Abstract

Background: Awareness of preferences regarding medical care should be a central component of the care of patients with advanced cancer. Open communication can facilitate this but can occur in an ad hoc or variable manner. Advance care planning (ACP) is a formalized process of communication between patients, relatives and professional caregivers about patients’ values and care preferences. It raises awareness of the need to anticipate possible future deterioration of health. ACP has the potential to improve current and future healthcare decision-making, provide patients with a sense of control, and improve their quality of life.Methods/Design: We will study the effects of the ACP program Respecting Choices on the quality of life of patients with advanced lung or colorectal cancer. In a phase III multicenter cluster randomised controlled trial, 22 hospitals in 6 countries will be randomised. In the intervention sites, patients will be offered interviews with a trained facilitator. In the control sites, patients will receive care as usual. In total, 1360 patients will be included. All participating patients will be asked to complete questionnaires at inclusion, and again after 2.5 and 4.5 months. If a patient dies within a year after inclusion, a relative will be asked to complete a questionnaire on end-of-life care. Use of medical care will be assessed by checking medical files. The primary endpoint is patients’ quality of life at 2.5 months post-inclusion. Secondary endpoints are the extent to which care as received is aligned with patients’ preferences, patients’ evaluation of decision-making processes, quality of end-of-life care and cost-effectiveness of the intervention. A complementary qualitative study will be carried out to explore the lived experience of engagement with the Respecting Choices program from the perspectives of patients, their Personal Representatives, healthcare providers and facilitators.Discussion: Transferring the concept of ACP from care of the elderly to patients with advanced cancer, who on average are younger and retain their mental capacity for a larger part of their disease trajectory, is an important next step in an era of increased focus on patient centered healthcare and shared decision-making.Trial registration: International Standard Randomised Controlled Trial Number: ISRCTN63110516 . Date of registration: 10/3/2014.

Details

ISSN :
14712407
Volume :
16
Database :
OpenAIRE
Journal :
BMC Cancer
Accession number :
edsair.doi.dedup.....f63061c12480dcaa606a703bdddae359
Full Text :
https://doi.org/10.1186/s12885-016-2298-x